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Carotid Endarterectomy in Asymptomatic Patients With Limited Life
Expectancy
Wallaert JB, De Martino RR, Finlayson SRG, et al. Stroke 2012;43:1781-7
Conclusion: Carotid endarterectomy (CEA) is commonly performed
in asymptomatic patients with life-limiting conditions. The net benefit of
CEA in this population is uncertain.
Summary: Numerous guidelines are in place regarding which patients
with asymptomatic carotid stenosis should be considered for prophylactic
CEA. The Society for Vascular Surgery guidelines indicate that asymptom-
atic patients with 60% carotid artery stenosis can be considered for CEA
when life expectancy is 3 years and the perioperative stroke and death risk
is 3% (Ricotta JJ et al, J Vasc Surg 2011;54e1-e31). Other societies have
more strict indications and assert that appropriate candidates should have a
life expectancy 5 years (Goldstein LB et al, Stroke 2011;42:517-84; and
Chaturvedi S et al, Neurology 2005;65:794-801). The American Academy
ofNeurology (Chaturvedi S et al, reference) supports CEA for asymptomatic
disease only if patients are aged75 years. However, anecdotally, it appears
many patients undergo CEA outside of societal guidelines. The authors
sought to examine how commonly CEA was performed in asymptomatic
patients with limited life expectancy. They used the American College of
Surgeons National Quality Improvement Project data to identify eight
conditions associated with limited life expectancy based on survival estimates
using external sources: disseminated cancer, advanced liver disease, symp-
tomatic congestive heart failure, dialysis dependence, severe chronic ob-
structive pulmonary disease, age 90 years, American Society of Anesthesi-
ologist class 4, and do-not-resuscitate (DNR) status as indicators of limited
life expectancy. The predicted 5-year mortality in all but the DNR group
varies from 46% to 83%. Comparisons were then made of 30-day stroke rate,
death, and myocardial infarction after CEA between asymptomatic patients
with and without life-limiting conditions. There were 12,631 CEAs per-
formed in asymptomatic patients, of which 2,525 (20%) were performed in
patients with life-limiting conditions or diagnoses. The most common
conditions were severe chronic obstructive pulmonary disease and American
Society of Anesthesiologist class 4 designation. Patients with life-limiting
conditions had higher rates of perioperative complications, including stroke,
(1.8% vs 0.9%, P  .01), death (1.4% vs 0.3%, P  .01), and stroke/death
(2.9% vs 1.1%, P .001). After adjustment for other comorbidities, patients
with life-limiting conditions were still nearly three times more likely to
experience perioperative stroke or death than those without these conditions
(odds ratio, 2.1; 95% confidence interval, 2.1-3.8; P .001). The incidence
of myocardial infarction was 1%.
Comment: The data as presented in the original abstract are a bit
misleading. Of the nearly 13,000 patients undergoing prophylactic CEA,
the very large majority deemed to have life threatening conditions had severe
chronic obstructive pulmonary disease or American Society of Anesthesiol-
ogist class 4. Only 10 patients had advanced liver disease, 21 had advanced
cancer, 25 patients had a DNR status, 108 were aged 90 years, and 110
were dialysis-dependent. The decision to perform surgery is an individual
one between the physician and the patient. Data such as this are never privy
to individual circumstances surrounding operative decisions. For example,
clearly not all 90-year-old patients and not all dialysis-dependent patients are
the same. Conversely, as pointed out by the authors, the National Quality
Improvement Project database may underestimate perioperative myocardial
infarction and stroke. Nevertheless, although prophylactic CEA may be an
overused procedure, the stroke and death rates in the patients with so-called
limited life expectancy were actually less than those advocated by the American
Heart Association for patients with asymptomatic carotid stenosis. Without
actual survival data on the so-called patients with limited life expectancy, the
report can be considered a bit more inflammatory than informative.
Endovascular Suitability and Outcome After Open Surgery for Rup-
tured Abdominal Aortic Aneurysm
Dick F, Diehm N, Opfermann P, et al. Br J Surg 2012;99:940-47.
Conclusion: Endovascular suitability is an independent and strongly
positive predictor of survival after open repair of ruptured abdominal aortic
aneurysm (rAAA).
Summary: Analyses of open vs endovascular repair of rAAA suggest
improved procedure-related mortality rates with endovascular repair of
rAAA (Harkin DW et al, Eur J Vasc Endovasc Surg 2007;34:673-81; and
Smith J et al, Eur J Vasc Endovasc Surg 2002;23:336-43). However, a
randomized comparison of endovascular vs open repair for rAAA did not
demonstrate a survival advantage for endovascular repair (Hinchliffe RJ et al,
Eur J Vasc Endovasc Surg 2006;32:506-13). The present study sought to
test the hypothesis that endovascular suitability itself predicts survival after
surgery for rAAA. The authors used two blinded investigators to indepen-
dently evaluate preoperative CT angiograms of consecutive patients with
rAAA. When assessments of suitability agreed between the two observers,
patients were categorized as “suitable” or “unsuitable” for endovascular
repair. If assessments disagreed, patients were classified as “borderline suit-
able.” Correlations between endovascular suitability and clinical outcome
were adjusted for suspected compounding factors and tested for robustness
using sensitivity analysis. Between January 2001 and December 2010, 237
of 248 patients with rAAA (95.6%) underwent open repair. Seventy patients
(28.2%) were classified as suitable, 100 (40.3%) as unsuitable for endovas-
cular repair, and 63 (25.4%) were considered borderline suitable for endo-
vascular repair. Postoperative 30-day mortality was 15.3% (38 deaths).
Multiple logistic regression analysis demonstrated that the odds of preoper-
ative death increased 9.2-fold (95% confidence interval, 2.16-39.23) for
“unsuitable” rAAA (P .003) and 6.80-fold (1.47-31.49) for “borderline”
“rAAA” (P  .014) compared with “suitable” rAAA. The selection affect
was sustained for 5 years of follow-up.
Comment: The authors’ overall results for repair of rAAA with open
surgery are superior to most other results reported. In the authors’ center,
endovascular repair of rAAA is therefore not likely to lead to a dramatic
increase in survival of the rAAA patient. The authors point out that other,
often forgotten measures, such as rapid diagnosis, rapid transfer, low-
volume resuscitation, systematic imaging, dedicated cardiovascular anesthe-
sia, and a high volume of rAAA repairs are all factors that contribute to
survival of the rAAA patient. At this point the available literature, as an
aggregate, would suggest that endovascular and open repair of rAAA can
both be effective procedures in the hands of appropriately trained and
experienced surgeons.
Long-Term Outcome of Aortic Dissection With Patent False Lumen:
Predictive Role of Entry Tear Size and Location
Evangelista A, Salas A, Ribera A, et al. Circulation 2012;125:3133-41.
Conclusion: A patent false lumen after aortic dissection has a high risk
of complications. Marfan syndrome, aortic diameter, and a large entry tear
located in the proximal part of the dissection identify high-risk subgroups of
patients who may benefit from earlier and more aggressive therapy.
Summary: Persistence of a patent false lumen in the descending aorta
after type A or type B aortic dissection is associated with poor prognosis
(Bernard Y et al, Am J Cardiol 2001;87:1378-82). The expectation was that
thoracic endovascular aortic repair for earlymanagement of aortic dissection,
by occluding the intimal tear and promoting false lumen thrombosis, would
result in better outcomes for the aortic dissection patient. To date however,
no study has demonstrated that elective endovascular treatment in the early
course of aortic dissection reduces mortality. In fact, the INSTEAD trial
failed to show a benefit in 2-year survival and adverse event rates after early
treatment of type B aortic dissection (Nienaber AN et al, Circulation
2009;120:2519-28). The “logic” of treating aortic dissection in the sub-
acute phase with endografts, coupled with the results of the INSTEAD trial,
has led investigators to try to identify clinical and imaging predictors of
prognosis and therefore, by inference, which patients may benefit from early
intervention after thoracic aortic dissection. The authors sought to define
such clinical and imaging variables in the subacute phase of aortic dissection.
They analyzed 184 consecutive patients: 108 surgically treated type A and
76 medically treated type B dissections who were discharged after acute
aortic dissection with a patent false lumen. Before discharge, transesopha-
geal echocardiograms were preformed. Computed tomography angiogra-
phy was performed at 3 months and yearly thereafter. Median follow-up was
6.42 years (quartile 1 to 3: 3.31 to 10.49). During follow-up, 49 patients
died (22 type A, 27 type B), of which 31 deaths were sudden deaths. Late
surgical or endovascular treatment was indicated in 10 type A and 25 type B
patients. Survival free from sudden death and surgical/endovascular treat-
ment was 0.90, 0.81, and 0.46 (95% confidence interval, 0.36-0.55) at 3, 5,
and 10 years, respectively. Multivariate analysis identified maximum baseline
descending aortic diameter (hazard ratio [HR], 1.32 [1.10-1.59]; P 
.003), proximal location (HR, 1.84 [1.06-3.19]; P  .03), and entry tear
size (HR, 1.13 [1.08-1.2]; P  .001) as predictors of dissection-related
adverse events. Mortality was predicated by maximum descending aortic
diameter (HR, 1.36 [1.08-1.70]; P  .008), entry tear size (HR, 1.1
[1.04-1.16]; P .001), and Marfan syndrome (HR, 3.66 [1.65-8.13]; P
.001).
Comment: This study focuses on clinical and imaging predictors
potentially identified early on after type A or type B dissection that may affect
late mortality or need for further intervention. Given the results of the
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